UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Expedia Group
EXPE
$36.4B
| $55.1M | 0.05% |
504,028
-3,862
| -0.8% | -$399K |
|
377
Voya Financial
VOYA
$9.08B
| $55.1M | 0.05% |
1,185,954
+129,721
| +12% | +$5.84M |
|
378
Lam Research
LRCX
$353B
| $55M | 0.05% |
6,761,380
-176,370
| -3% | -$1.38M |
|
379
Eversource Energy
ES
$27.2B
| $54.6M | 0.05% |
1,202,961
-6,706
| -0.6% | -$325K |
|
|
JNPR
380
DELISTED
Juniper Networks
JNPR
| $54.6M | 0.05% |
2,101,453
-133,091
| -6% | -$3.49M |
|
|
MXIM
381
DELISTED
Maxim Integrated Products
MXIM
| $54.4M | 0.05% |
1,574,434
+694,567
| +79% | +$23.8M |
|
|
ALTR
382
DELISTED
Altera Corp
ALTR
| $54.4M | 0.05% |
1,063,148
-6,176,045
| -85% | -$288M |
|
383
SL Green Realty
SLG
$3.84B
| $54.2M | 0.05% |
509,531
+38,989
| +8% | +$4.57M |
|
384
Marriott International
MAR
$93.4B
| $54.1M | 0.05% |
727,798
-5,295
| -0.7% | -$418K |
|
385
Regions Financial
RF
$26.8B
| $54M | 0.05% |
5,214,479
+13,380
| +0.3% | +$135K |
|
386
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| – | – |
0
| – | – |
|
387
Federal Realty Investment Trust
FRT
$10.7B
| $53.6M | 0.05% |
418,756
-15,334
| -4% | -$2.08M |
|
388
DaVita
DVA
$15.8B
| $53.6M | 0.05% |
674,874
-7,890
| -1% | -$648K |
|
389
Coca-Cola Europacific Partners
CCEP
$48.2B
| $53.6M | 0.05% |
1,233,120
+138,093
| +13% | +$6.19M |
|
390
GameStop
GME
$8.63B
| $53.2M | 0.05% |
4,953,388
+826,780
| +20% | +$8.5M |
|
391
JD.com
JD
$44.8B
| $53M | 0.05% |
1,554,233
+415,000
| +36% | +$14.1M |
|
|
ANDV
392
DELISTED
Andeavor
ANDV
| $52.9M | 0.05% |
626,357
+1,593
| +0.3% | +$138K |
|
|
NBL
393
DELISTED
Noble Energy, Inc.
NBL
| $52.8M | 0.05% |
1,238,142
+44,222
| +4% | +$2.09M |
|
394
Expeditors International
EXPD
$22B
| $52.6M | 0.05% |
1,141,060
+116,867
| +11% | +$5.5M |
|
395
Roper Technologies
ROP
$39.3B
| $52.6M | 0.05% |
304,868
-1,364
| -0.4% | -$236K |
|
396
Lexicon Pharmaceuticals
LXRX
$1.01B
| $52.1M | 0.05% |
6,473,674
+1,002,004
| +18% | +$7.36M |
|
397
Whirlpool
WHR
$2.57B
| $52M | 0.05% |
300,760
+7,864
| +3% | +$1.48M |
|
398
Nucor
NUE
$57.5B
| $51.9M | 0.05% |
1,178,607
-14,566
| -1% | -$699K |
|
399
M&T Bank
MTB
$36.1B
| $51.4M | 0.05% |
411,678
-8,319
| -2% | -$1.02M |
|
400
MDU Resources
MDU
$4.17B
| $51.4M | 0.05% |
6,924,400
-414,347
| -6% | -$3.33M |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.